ID: MRFR/Pharma/1398-CR | October 2019 | Region: Global | 92 Pages
1 Research Scope & Methodology
1.1 Market Definition 10
1.2 Market Breakdown by Type of Tests, Sample 10
1.3 Market Breakdown by Geography 11
1.4 Research Methodology and Sources 11
2 Executive Summary
2.1 Key Findings 13
2.2 Research Summary 13
3 Market Outlook
3.1 Introduction 15
3.1.1 International Drug Trafficking 15
3.1.2 Drug Trafficking and Illicit Drug Use in North America 16
3.1.3 Drug Trafficking and Illicit Drug Use in Europe 16
3.1.4 Drug Trafficking and Illicit Drug Use in Asia-Pacific 16
3.2 Technology Analysis – Drug Abuse Testing Market 17
3.2.1 Chromatography Technology 17
3.2.2 Immunoassay Technology 17
3.3 Single vis-Ă -vis Multiple Parameter Test 18
3.4 Factors Driving the Market and its Impact on Market Forecast 19
3.4.1 Increased Use of Drug Testing at Organizational Level 19
3.4.2 Increased Production and Trade of Illicit Drugs Worldwide 20
3.4.3 Global Increase in Road Accidents and Death Rates 20
3.4.4 Increase in the Consumption of Illegal Drugs 20
3.4.5 Impact Analysis of Drivers on Market Forecast 21
3.5 Factors Hindering the Market and its Impact on Market Forecast 21
3.5.1 Legalization of Drugs 21
3.5.2 Social Issues Associated with Drug Abuse Testing 22
3.5.3 Inability of Testing Products to Detect Low-Dose Designer Drugs 22
3.5.4 Impact Analysis of Restraints on Market Forecast 23
4 Global Market Size & Forecast (2020-2027)
4.1 Global Market Breakdown by Type of Test 24
4.2 Global Market Breakdown by Sample 25
4.3 Global Market Breakdown by Region 27
5 Global Market Breakdown by Type of Test
5.1 Onsite Testing 29
5.2 Laboratory Testing 29
5.3 The North American Market by Type of Test 30
5.3.1 US Drugs of Abuse Market by Type of Test 32
5.4 The European Market by Type of Test 33
5.4.1 UK Drugs of Abuse Market, by Type of Test 34
5.4.2 Germany Drugs of Abuse Market by Type of Test 34
5.4.3 France Drugs of Abuse Market, by Type of Test 35
5.5 Asia-Pacific Market by Type of Test 36
5.5.1 India Drugs of Abuse Market by Type of Test 37
5.5.2 China Drugs of Abuse Market, by Type of Test 38
5.5.3 Japan Drugs of Abuse Market, by Type of Test 38
6 Global Market Breakdown by Sample
7 Global Market Breakdown by Region
7.1 North America Market Breakdown by Country 43
7.1.1 Drug Abuse Market Scenario in the US. 44
7.2 Europe Market Breakdown by Country 45
7.2.1 Drug Abuse Market Scenario in the UK. 46
7.2.2 Drug Abuse Market Scenario in France 46
7.2.3 Drug Abuse Market Scenario in Germany 47
7.3 Asia-Pacific Market Breakdown by Country 47
7.3.1 Drug Abuse Market Scenario in India 49
7.3.2 Drug Abuse Market Scenario in China 50
7.3.3 Drug Abuse Market Scenario in Japan 51
8 Competitive Analysis and Market Share
Porter's Five Forces of Competitive Position Analysis 52
8.1.1 Bargaining Power of Buyers 52
8.1.2 Bargaining Power of Suppliers 53
8.1.3 Threat of New Entrants 53
8.1.4 Intensity of Rivalry 53
8.1.5 Threat of Substitutes 53
9 Company Profiles
9.1 Roche Holding Limited 54
9.1.1 Business Overview 54
9.1.2 Products and Services 54
9.1.3 Recent Developments 55
9.2 Quest Diagnostics 55
9.2.1 Business Overview 55
9.2.2 Products and Services 56
9.2.3 Recent Developments 56
9.3 Laboratory Corporation of America Holdings 56
9.3.1 Business Overview 57
9.3.2 Products and Services 57
9.3.3 Recent Developments 57
9.4 Alere Inc. 58
9.4.1 Business Overview 58
9.4.2 Products and Services 58
9.4.3 Recent Developments 58
9.5 Abbott Laboratories 59
9.5.1 Business Overview 59
9.5.2 Products and Services 59
9.5.3 Recent Developments 60
9.6 Randox Laboratories Ltd 60
9.6.1 Business Overview 60
9.6.2 Products and Services 61
9.6.3 Recent Developments 62
9.7 Psychemedics Corporation 62
9.7.1 Business Overview 62
9.7.2 Products and Services 62
9.7.3 Recent Developments 62
9.8 Bio-Rad Laboratories, Inc. 63
9.8.1 Business Overview 63
9.8.2 Products and Services 63
9.8.3 Recent Developments 63
9.9 Sonic Healthcare 64
9.9.1 Business Overview 64
9.9.2 Products and Services 64
9.9.3 Recent Developments 65
9.10 Thermo Fisher Scientific Inc. 66
9.10.1 Business Overview 66
9.10.2 Products and Services 66
9.10.3 Recent Developments 67
10 Appendix
10.1 List of Abbreviations 68
11 List of Tables
TABLE 1 SPECIFIC PRIMARY AND SECONDARY SOURCES USED FOR THIS PUBLICATION 12
TABLE 2 GLOBAL DRUG ABUSE TESTING MARKET SNAPSHOT(2020 AND 2027) 14
TABLE 3 WORLDWIDE NUMBER OF ILLICIT DRUG USERS, BY MAJOR DRUGS, % SHARE(2027) 15
TABLE 4 MULTIPLE PARAMETER TEST ADVANTAGES OVER SINGLE PARAMETER TEST 19
TABLE 5 DRIVERS FOR THE MARKET: IMPACT ANALYSIS 21
TABLE 6 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS 23
TABLE 7 GLOBAL MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 24
TABLE 8 GLOBAL MARKET BREAKDOWN BY TYPE OF TEST, $M (2027) 25
TABLE 9 GLOBAL MARKET BREAKDOWN BY SAMPLE, $M (2020–2027) 26
TABLE 10 GLOBAL MARKET BREAKDOWN BY SAMPLE, $M (2020–2027) 26
TABLE 11 GLOBAL MARKET BREAKDOWN BY REGION, $M (2020–2027) 27
TABLE 12 GLOBAL MARKET BREAKDOWN BY REGION, $M (2020–2027) 28
TABLE 13 ONSITE SCREENING TEST—ADVANTAGES AND DISADVANTAGES 29
TABLE 14 LABORATORY DRUG TEST—ADVANTAGES AND DISADVANTAGES 30
TABLE 15 NORTH AMERICA MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 31
TABLE 16 NORTH AMERICA MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 31
TABLE 17 US MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2020) 32
TABLE 18 US MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 32
TABLE 19 EUROPE MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2020) 33
TABLE 20 EUROPE MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 33
TABLE 21 UK MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 34
TABLE 22 UK MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 34
TABLE 23 GERMANY MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 35
TABLE 24 GERMANY MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 35
TABLE 25 FRANCE MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 35
TABLE 26 FRANCE MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 36
TABLE 27 ASIA-PACIFIC MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 36
TABLE 28 ASIA-PACIFIC MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 36
TABLE 29 INDIA MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 37
TABLE 30 INDIA MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 37
TABLE 31 CHINA MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 38
TABLE 32 CHINA MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 38
TABLE 33 JAPAN MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 39
TABLE 34 JAPAN MARKET BREAKDOWN BY TYPE OF TEST, $M (2020–2027) 39
TABLE 35 SAMPLE ANALYSIS—ADVANTAGES AND DISADVANTAGES 40
TABLE 36 NORTH AMERICA MARKET BREAKDOWN BY REGION, $M (2020–2027) 43
TABLE 37 NORTH AMERICA MARKET BREAKDOWN BY REGION, $M (2020–2027) 44
TABLE 38 EUROPE MARKET BREAKDOWN BY REGION, $M (2020–2027) 45
TABLE 39 EUROPE MARKET BREAKDOWN BY REGION, $M (2020–2027) 46
TABLE 40 ASIA-PACIFIC MARKET BREAKDOWN BY REGION, $M (2020–2027) 49
TABLE 41 ASIA-PACIFIC MARKET BREAKDOWN BY REGION, $M (2020–2027) 49
TABLE 42 ROCHE HOLDINGS—KEY FACTS 54
TABLE 43 QUEST DIAGNOSTICS—KEY FACTS 55
TABLE 44 LABORATORY CORPORATION OF AMERICA HOLDINGS—KEY FACTS 56
TABLE 45 ALEREINC—KEY FACTS 58
TABLE 46 ABBOTT LABORATORIES—KEY FACTS 59
TABLE 47 RANDOX LABORATORIES—KEY FACTS 60
TABLE 48 PSYCHEMEDICS CORPORATION—KEY FACTS 62
TABLE 49 BIO-RAD LABORATORIES—KEY FACTS 63
TABLE 50 SONIC HEALTHCARE—KEY FACTS 64
TABLE 51 THERMO FISHER SCIENTIFIC INC.—KEY FACTS 66
12 List of Figures
FIG 1 GLOBAL DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST (2020) 24
FIG 2 GLOBAL DRUG ABUSE TESTING MARKET SHARE BY SAMPLE (2020) 25
FIG 3 GLOBAL DRUG ABUSE TESTING MARKET SHARE BY REGION (2020) 27
FIG 4 GLOBAL DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST (2020) 30
FIG 5 THE NORTH AMERICAN DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST (2020) 31
FIG 6 THE EUROPEAN DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST (2020) 33
FIG 7 ASIA-PACIFIC DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST, 2020 37
FIG 8 GLOBAL DRUG ABUSE TESTING MARKET SHARE, BY SAMPLE, 2020 42
FIG 9 NORTH AMERICA DRUG ABUSE TESTING MARKET SHARE BY COUNTRY(2020) 43
FIG 10 EUROPE DRUG ABUSE TESTING MARKET SHARE BY COUNTRY (2020) 45
FIG 11 ASIA-PACIFIC DRUG ABUSE TESTING MARKET SHARE BY COUNTRY (2020) 48
FIG 12 PORTER’S FIVE FORCES OF COMPETITIVE POSITION ANALYSIS 52
$6,673.3 million
7.77%
North America
2022-2030
Drug of Abuse Testing Market Overview
Globally, it has been marked that the drug of abuse testing market occupies a CAGR of 7.77% and to reach USD 6,673.3 million during the market forecast period of 2018-2025. The present-day modern lifestyle so adopted by the people pushes them to consume drugs and then after it leads to drug abuse. The government has carried out DOA testing for preventing illegal activities by drug abuse.
COVID 19 ANALYSIS
The outbreak of COVID had a great impact on the drug of abuse testing market. The government announced isolation and quarantine to those people who were suffering from COVID or had traveled from other parts of the region. Isolation and quarantines had a bad impact on the drug abusers. Lockdown and shutdown measures so imposed t6o avoid the spread of Corona led to the rise in abuse of drugs and alcohol. Drug abusers during the time of COVID were highly dependent on healthcare and public organizations to decrease the health outcomes among the population. This showed that the drug of abuse testing market was severely affected during the time of the pandemic.
MARKET DYNAMICS
MARKET SEGMENTATION
REGIONAL ANALYSIS
The North American market is expected to cover a large area of market share. Here the government is taking serious steps against the drug abusers. Likewise, the government is taking serious steps for monitoring the symptoms and to determine the intensity of drugs in a body. America is the world's most dominant market due to the increase in the usage of drugs. Testing drugs is an important part of every organization, transportation, corporate sector, and many others. European regions like France, Germany, United Kingdom, Spain, Italy are said to be the second most dominant religion throughout the market. The anti-drug drive is in high demand due to an increase in road accidents done by alcoholic and drunk people. Asia-Pacific countries include the regions of China, India, Australia, and Brazilian regions where a hike in the drug of abuse testing market was marked and stringent rules and regulations were put forward by the government.
COMPETITIVE LANDSCAPE
Rising drug of abuse testing market services by adopting different market trends made the key players compete with other market players. The key players have worked by adopting different products and have made a good product portfolio. They have used drug abuse test market technology and have launched new substances for covering large market shares. Some of them are Abbott Laboratories, Quest Diagnostics Incorporated, Express Diagnostics, Thermo Fisher Scientific Inc., Siemens AG, Pfizer, Drager Work KG, and Co KGAA, Orasure, Hoffmann La-Roche AG, Premier Biotech, MPD, Alfa Scientific Designs, SureHire, LifeLock, Omega Laboratories, CannAmm, Shimadzu, Psychemedics, Laboratories Corporation of America Holdings(LabCorp), Randox Laboratories, Sonic Healthcare, Bio-Rad Laboratories and many more. These companies along with government organizations have planned various strategies that may lead to the adoption of the drug of abuse testing devices market. This pharma company has been investing large sums of revenue in discovering new drugs for the treatment of various diseases.
RECENT DEVELOPMENTS
REPORT OVERVIEW
The report on the drug abuse testing market gave insights into the research and also gave a good analysis of the drugs and drug industry. It gives insights into the market scenario and makes a good evaluation of its current trends which has a great impact on future growth. It gives a piece of good information about the factors that increases the opportunities of the market and the factors that drive the market size. It also signifies the challenges faced by the drug abuse testing market. The report gives a good analysis of the market segments that helps in driving the drug abuse screening test market. It gives insights into the competitive outlook of the regions and the key players operating in the market. The report shows the importance of drug abuse screening tests for the population who always wants to adopt a healthier lifestyle and guide the public to avoid consuming drugs and other additives.
Report Attribute/Metric | Details |
---|---|
Market Size | 6,673.3 Million (2025) |
CAGR | 7.77% (2019-2025) |
Base Year | 2019 |
Forecast Period | 2027 |
Historical Data | 2018 |
Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Type of Test, Sample |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors | Abbott Laboratories, Quest Diagnostics Incorporated, Express Diagnostics, Thermo Fisher Scientific Inc., Siemens AG, Pfizer, Dragerwerk AG & Co. KGAA, OraSure, Hoffmann-La Roche AG, Premier Biotech, Alfa Scientific Designs, MPD, SureHire, Lifeloc, Omega Laboratories, CannAmm, Shimadzu, Psychemedics, Laboratory Corporation of America Holdings (LabCorp), Randox Laboratories, Sonic Healthcare, Bio-Rad Laboratories. |
Key Market Opportunities | New product launches and R&D Amongst major key Players |
Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
The drug of abuse testing market is projected to grow at a 7.77% CAGR between 2016-2025.
North America is expected to dominate the drug of abuse testing market.
The drug of abuse testing market is predicted to touch USD 6,673.3 million by 2025.
Increased use of drug testing, rising consumption of illegal drugs, and increase in road accidents are boosting market growth.
Social issues related to drug abuse testing may limit market growth.